The work in colon cancer by Dr. Enza Lonardo has been selected through an open competition and external evaluation following the quality standards of the Spanish Cancer Association (ACCC).
This study seeks to find a way to slow down the development of the disease and unravel the metastatic mechanism.
Each year the “Carmen Lavigne Hinojosa” Award for Research dedicates 60,000 euros to cancer research projects of excellence performed in Spain.
IRB Barcelona is to coordinate a Horizon2020 bioinformatics project that seeks to lay the groundwork for the emerging field of 3D genomics.
3D genomics provides information about the structures adopted by folded DNA inside a cell and about how they change over time and in response to alterations in cell environment. Modesto Orozco, the coordinator of the project says, “The 3D perspective will allow us to better relate changes in the genome with the corresponding diseases, because although 1D information is relevant, it falls short.”
Over three years, the project aims to provide a set of methods and integrated databases that can be used to store and process the data deriving from studies devoted to 3D genomics.
The European consortium comprises six international leading centres in method development and visualisation in 3D genomics.
Around 400 people gathered in a charity wine-tasting event to raise funds for metastasis research conducted at IRB Barcelona.
IRB Barcelona participates in the fifth edition of the programme “Teachers and Science”, an initiative of the Catalunya-La Pedrera Foundation.
The medicine of the future starts here. Visit the Institute's proposal
The charity organisation headed by the sommelier Xavi Ayala, from Mollerussa, is to organise its 5th charity wine-tasting event for 450 people on 28 November in Calella.
For 5 euros, participants will have the chance to taste 6 wines from various DO (Designation of Origin) regions of Catalonia.
Tomorrow, Thursday 5 November at 19h, Joan Guinovart will give a public talk on the keys to a disease that has become an epidemic of the XXI century.
It has been known for 100 years that the brain is protected by thousands of tight capillaries that form a barrier—a defence mechanism but also an obstacle to the use of promising drugs to treat diseases affecting the central nervous system.
Ernest Giralt: “This barrier is responsible for the low success rate of new drugs to enter the brain. We now have the strategies to overcome it.”
20 pioneering scientists present their latest research on the barrier and the breakthroughs in therapeutic shuttle transporters that target the brain in the Blood-Brain-Barrier Conference, an event organised by IRB Barcelona and supported by the BBVA Foundation.
One of the latest results is a shuttle based on bee venom developed at IRB Barcelona.
Today the Ministry of the Economy and Competiveness has announced that the Severo Ochoa Award given to 8 centres in the first call in 2011 has been renewed for another four years
The award brings with it another 4 million euros (1 per year) for IRB Barcelona
The National Bioinformatics Institute (INB) acts as the Spanish scientific node and coordinates the partner institutions. These comprises CNIO, CRG, UPF, BSC and IRB Barcelona